Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFadel Partners Regulatory News (FADL)

Share Price Information for Fadel Partners (FADL)

Share Price is delayed by 15 minutes
Get Live Data
41.50    0.00 (0.00%)
Bid:
40.00
Ask:
43.00
Spread: 3.00 (7.50%)
Market Cap: £8.40m
FADL Live PriceLast checked at - London Stock Exchange

Intraday Fadel Partners Share Chart

Investor Presentation

20 Apr 2026 07:00

RNS Number : 0170B
Fadel Partners Inc.
20 April 2026
 

Fadel Partners, Inc.

('FADEL', the 'Company' or, together with its subsidiaries, the 'Group')

Investor Presentation via Investor Meet Company

FADEL (AIM: FADL), a global leader in AI-driven brand compliance and licensing software, announces that Tarek Fadel, Chief Executive Officer, and Mark Plotkin, Chief Financial Officer, will provide a live presentation relating to the Group's Annual Results via Investor Meet Company on 01 May 2026 at 15:00 BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 30 April 2026 at 09:00 BST, or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet FADEL via the following link:https://www.investormeetcompany.com/fadel-partners-inc/register-investor

Investors who already follow FADEL on the Investor Meet Company platform will automatically be invited.

The Group's full year audited results for the year ended 31 December 2025 will be announced on 30 April 2026.

This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").

For further information, please contact:

Tarek Fadel, Chief Executive OfficerMark Plotkin, Chief Financial Officer

Cavendish Capital Markets Limited (Nomad & Broker)Jonny-Franklin Adams, Isaac Hooper (Corporate Finance)Sunila De Silva (ECM)Tel: +44 (0)20 7220 0500

 

FADEL Strategic Communications Devi Guptapress@fadel.com

About Fadel Partners Inc.

FADEL delivers AI-enabled software to manage brand compliance and IP licensing with precision and confidence. Its cloud-based platforms help organizations govern content and usage rights at scale, streamline complex licensing and royalty processes, and reduce risk across global operations. Trusted by some of the world's most recognized brands in media, publishing, consumer goods, high-tech, and advertising, FADEL empowers teams to protect intellectual property, accelerate licensing workflows, and operate with clarity in an increasingly complex digital ecosystem.

The Group's main country of operation is the United States, where it is headquartered in New York, with further operations in the UK, France, Lebanon and Jordan.

For more information, please visit the Group's website at: www.fadel.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCILMMTMTMBBRF
Date   Source Headline
30th Apr 20267:00 amRNSResults for the year ended 31 December 2025
20th Apr 20267:00 amRNSInvestor Presentation
28th Jan 20267:00 amRNS2025 Trading Update and FY 2026 Outlook
22nd Oct 20253:37 pmRNSGrant of Options
15th Oct 20252:38 pmRNSResult of AGM
14th Oct 20257:00 amRNSAGM and Trading Update
19th Sep 20257:00 amRNSNotice of AGM
5th Sep 20257:00 amRNSHalf-year Report
30th Jul 20257:00 amRNSHalf Year Trading Update
13th May 20255:55 pmRNSHolding(s) in Company
9th May 20257:00 amRNSDirector Share Dealings
7th May 20257:00 amRNSHolding(s) in Company
6th May 20257:00 amRNSDirector Share Dealings
30th Apr 20257:00 amRNSResults for the year ended 31 December 2024
3rd Feb 20257:00 amRNSEBT Share Purchase
27th Jan 20257:00 amRNS2024 Trading Update and FY 2025 Outlook
7th Nov 20247:00 amRNSUpdate to FY 25 Trading Expectations
25th Sep 20247:00 amRNSHalf Year Report
13th Sep 20247:00 amRNSInvestor Presentation via Investor Meet Company
20th Aug 20245:30 pmRNSResult of AGM
15th Aug 20247:00 amRNSRemoval of Regulation S Restrictions
31st Jul 20247:00 amRNSHalf Year Trading Update and Notice of AGM
2nd Jul 20247:00 amRNSBoard Appointment and Director Changes
14th Jun 20247:00 amRNSNotice of the postponement of AGM
3rd Jun 20247:00 amRNSNew Contract Wins
23rd May 20247:00 amRNSBoard Observer
10th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20247:00 amRNSResults for the year ended 31 December 2023
2nd Apr 20247:00 amRNSNotice of Results and Presentation
22nd Mar 20247:00 amRNSGrant of Options
1st Mar 20247:00 amRNSLaunch of LicenSeeâ„¢
26th Feb 20247:00 amRNSDirectorate Change
13th Feb 20247:00 amRNSDirectorate Change
31st Jan 20247:00 amRNSTrading Update
29th Nov 20237:00 amRNSResignation of Non-Executive Director
28th Nov 20237:00 amRNSMello Investor Presentations
27th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSNotice of Results and Investor Presentations
4th Aug 20237:00 amRNSExercise of Warrants and Total Voting Rights
25th Jul 20237:00 amRNSHalf Year Trading Update
21st Jul 20235:49 pmRNSResult of AGM
27th Jun 20237:00 amRNSInvestor Presentation
22nd Jun 20237:00 amRNSFinal Results and Notice of AGM
2nd May 20237:00 amRNSIssuance of Common Shares
20th Apr 20237:00 amRNSChange of Investment Manager/ Holdings in Company
12th Apr 20234:03 pmRNSHolding(s) in Company
11th Apr 20237:00 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.